Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 38 minutes ago
Back to Filings
FORM 4
AI

Insider Trading - November 18, 2024

Filed November 18, 2024
·
Period ending November 14, 2024
·
0000950170-24-128168

Director Ocko sold 5.37M shares (~$97M) indirectly via VC funds.

Brief

Matthew Ocko, a director of Rocket Lab USA, indirectly sold approximately 5.37 million shares through managed VC funds DCVC IV and DCVC Opportunity Fund II on Nov 14-15, 2024, for ~$97M at weighted averages of $17.73-$18.21. The sales were not pursuant to a 10b5-1 plan. This large discretionary selling signals bearish insider sentiment.

Detailed Brief

Director Matthew Ocko reported indirect sales of Common Stock via two entities he manages: Data Collective IV, L.P. (DCVC IV) and DCVC Opportunity Fund II. On 11/14/2024, 578,215 shares from DCVC IV and 1,421,785 from DCVC Opportunity Fund II were sold at a weighted average of $17.7262 (total ~2M shares, ~$35.5M). On 11/15/2024, 973,192 from DCVC IV and 2,393,001 from DCVC Opportunity Fund II at $18.2143 (~3.37M shares, ~$61.4M). Post-transaction holdings: DCVC IV ~1.38M shares, DCVC Opp ~3.39M shares, representing ~50% reduction in each fund's position. No 10b5-1 plan indicated. This is a massive discretionary sale by a director-linked VC, with no prior pattern context in filing, occurring amid recent stock strength.

Key Telemetry

  • Sold ~5.37M shares (~$97M), reducing each fund's holdings by ~50%.
  • Discretionary sales (no 10b5-1 plan), first reported in this period.
  • At prices near recent highs (~$18), post-runup timing.
  • Large size relative to holdings signals significant profit-taking.

Risk Signals

Insider Selling
Large discretionary sale >$1M (~$97M) and >10% (~50%) of holdings per fund, not under 10b5-1 plan.
5.37M shares sold

Impact Vector

This substantial discretionary sale by a director via managed funds indicates reduced insider confidence and profit-taking at elevated prices, potentially bearish for near-term stock momentum. Lack of 10b5-1 suggests deliberate timing amid recent gains.

Search
Search across missions, customers, news, and SEC filings